Clinical studies of lactobacilli showing efficacy for treatment of various pathologies
| Bacteria | Dose | Pathology | Ref. (Design) |
|---|---|---|---|
| L. casei Shirota | Not stated | Ventilator-associated pneumonia | 291(prospective, randomised, open-label controlled study) |
| Synbiotic 2000 (P. pentosaceus 5—33:3, L. mesenteroides 32–77:1, L. paracasei 19 and L. plantarum 2362 + inulin, β-glucan, resistant starch and pectin) | 1×1010 CFU (of each) Not stated | Severe acute pancreatitis | 292(prospective, randomised, double-blind study) |
| Ecologic 641®: (L. acidophilus, L. casei, L. salivarius, Lactococcus lactis, B. bifidum and B. lactis + cornstarch and maltodextrins) | 1010 CFU (total) Not stated | Severe acute pancreatitis | 293(multicentre randomised, double-blind, placebo-controlled study) |
| Genefilus F19© (L. paracasei subsp paracasei F19 + high-fibre diet) | 12×109 CFU Not stated | Symptomatic uncomplicated diverticular disease | 294(multicentre, randomised, controlled, open parallel-group study) |
| L. GG | > 5×1010 CFU | Cirrhosis | 295(open study) |